Having herpes antibodies means your immune system has encountered herpes simplex virus at some point, and your body made proteins to fight it. Nearly half of Americans aged 14 to 49 test positive for HSV-1 antibodies (47.8%), and about 12% test positive for HSV-2 antibodies. A positive antibody result does not tell you when you were infected, where the virus lives in your body, or whether you’ll ever have symptoms.
IgG vs. IgM: What Each Antibody Type Tells You
Herpes blood tests measure two different classes of antibodies, and they mean different things. IgG antibodies indicate past exposure. Your body produces them weeks after infection, and they persist for life. Most herpes blood tests look for IgG because it reliably confirms whether you’ve been exposed.
IgM antibodies indicate a more recent immune response. However, IgM testing for herpes is widely considered unreliable. IgM can reappear during later outbreaks (not just new infections), and it cross-reacts between HSV-1 and HSV-2, making results difficult to interpret. Most specialists discourage IgM testing for herpes.
How Long Antibodies Take to Appear
Your body doesn’t produce detectable IgG antibodies immediately after exposure. The median time from first symptoms to a positive IgG test is about three to five weeks, depending on the virus type and the test used. For HSV-2, the standard screening test (HerpeSelect ELISA) detected antibodies at a median of 21 days after symptom onset, while a more precise lab method (Western blot) took closer to 40 days. If you were tested too soon after a possible exposure, a negative result may not be accurate. Retesting after 12 weeks gives the most reliable picture.
The False Positive Problem With HSV-2 Tests
HSV-2 IgG blood tests report results as an index value. Anything at or above 1.1 is considered positive, but values between 1.1 and 3.0 have a high rate of false positives. In one large study, 56% of samples in that low-positive range turned out to be false positives when checked with a confirmatory test. By contrast, only 14% of samples with index values above 3.0 were false positives.
This matters a lot if you received a low-positive HSV-2 result. The CDC recommends that any initial HSV-2 IgG result between 1.1 and 3.0 be confirmed with a second, different test method. If your result falls in that range, ask your provider about confirmatory testing before assuming the result is accurate. A result with a high index value (above 3.0) is much more likely to reflect a true infection.
Antibodies Don’t Tell You Where the Virus Is
A blood test confirms exposure to HSV-1 or HSV-2, but it cannot tell you the location of your infection. HSV-1 is commonly associated with oral cold sores, but it also causes a growing share of genital herpes cases. HSV-2 almost always infects the genital area. Without a history of symptoms or a swab test from an active sore, you may not know where the virus established itself.
Location matters because it strongly affects how often outbreaks occur. HSV-2 in the genital area recurs most frequently, averaging about 0.33 episodes per month (roughly four per year). HSV-1 on the lips recurs less often, about 0.12 per month. HSV-1 in the genital area recurs rarely, averaging just 0.02 per month, or roughly once every four years. HSV-2 on the lips is the rarest pattern, with recurrences close to zero. So if your blood test shows HSV-1 antibodies, your experience could range from occasional cold sores to an essentially silent genital infection that almost never reactivates.
You Can Still Transmit the Virus Without Symptoms
Many people with herpes antibodies have never had a noticeable outbreak. That doesn’t mean the virus is completely dormant. Herpes periodically reactivates and reaches the skin surface without causing visible sores, a process called asymptomatic shedding. For genital HSV-2, this happens on roughly 1% to 3% of days. During those brief windows, the virus can be transmitted to a partner even though nothing looks or feels wrong.
Daily suppressive antiviral therapy reduces this risk substantially. In a large clinical trial, daily treatment cut the overall rate of HSV-2 transmission to partners by about 48%, and reduced the rate of symptomatic infections by 75%. Condom use provides additional protection on top of that. For couples where one partner has antibodies and the other doesn’t, combining daily antivirals with condoms offers the strongest available protection.
Why Routine Screening Isn’t Recommended
You might expect that a simple blood test for a common infection would be part of standard STI panels, but the CDC specifically recommends against routine herpes screening for people without symptoms. The reasons are practical: the false positive rate for HSV-2 (especially in the low-positive index range) is high enough to cause unnecessary distress, and a positive HSV-1 result in someone who has never had symptoms provides little actionable information.
Testing is recommended when you have genital symptoms that could be herpes, when a partner has been diagnosed with genital herpes, or when a provider sees signs of herpes during an exam and needs confirmation. In these situations, knowing your antibody status helps guide decisions about treatment and prevention. Outside of those scenarios, the test results often raise more questions than they answer.
What to Do With a Positive Result
If your antibody test came back positive, the most useful next steps depend on which virus type was detected and whether your result falls in a reliable range. For HSV-2, check your index value. If it’s between 1.1 and 3.0, confirmatory testing is worth pursuing before making any assumptions. If it’s above 3.0, the result is very likely accurate.
For HSV-1, a positive result most commonly reflects oral herpes acquired in childhood or adolescence. Nearly half the U.S. population carries these antibodies. Unless you’ve had genital symptoms, an HSV-1 positive result typically means you carry the virus orally, and many people with oral HSV-1 experience cold sores infrequently or not at all.
Regardless of type, having herpes antibodies means the virus remains in your body permanently, residing in nerve cells in a dormant state. It may reactivate occasionally, producing symptoms or shedding silently. For most people, outbreaks become less frequent over time. Suppressive antiviral therapy is available for those who experience frequent recurrences or want to reduce the chance of transmitting the virus to a partner.